Comparable Long-Term Outcomes of Cyclosporine and Infliximab in Patients With Steroid-Refractory Acute Severe Ulcerative Colitis: A Meta-Analysis

Background: In steroid-refractory acute severe ulcerative colitis (ASUC), cyclosporine (CYS) or infliximab (IFX) may be considered as a second-line alternative to avoid colectomy. There are short-term data reported, but until now, there is no meta-analysis regarding long-term outcomes of CYS and IFX...

Descripción completa

Detalles Bibliográficos
Autores principales: Szemes, Kata, Soós, Alexandra, Hegyi, Péter, Farkas, Nelli, Erős, Adrienn, Erőss, Bálint, Mezősi, Emese, Szakács, Zsolt, Márta, Katalin, Sarlós, Patrícia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985460/
https://www.ncbi.nlm.nih.gov/pubmed/32039218
http://dx.doi.org/10.3389/fmed.2019.00338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985460/
https://www.ncbi.nlm.nih.gov/pubmed/32039218
http://dx.doi.org/10.3389/fmed.2019.00338

Ejemplares similares